Study protocol for a survey on the epidemiology of hypertension in Tetouan, Morocco, using a stratified cluster sampling method
DOI:
https://doi.org/10.17533/udea.rfnsp.e359023Palabras clave:
population-based survey, epidemiology, hypertension, stratified cluster samplingResumen
Objective: To present the design and methodological framework of a protocol for a population-based cross-sectional survey aimed at assessing the prevalence, knowledge, treatment, and control of hypertension in Tetouan, Morocco.
Methods: A cross-sectional design was adopted. The study used a multistage stratified cluster sampling process, which required special attention to minimize potential biases and ensure efficient data collection.
Results: The article provides a detailed description of each phase of the survey process, beginning with initial planning, continuing with the sampling stages and physical measurements taken, and concluding with the statistical methods for data analysis. The methodology of the study was designed to provide reliable and current data on the epidemiology of hypertension in the region.
Conclusion: This research contributes valuable information for those planning or conducting similar population-based surveys.
Descargas
Citas
1. Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol. 2020;16(4):223–37. DOI: https://doi.org/10.1038/s41581-019-0244-2
2. Fuchs FD, Whelton PK. High blood pressure and cardiovascular disease. Hypertension. 2020;75(2):285–92. DOI: https://doi.org/10.1161/HYPERTENSIONAHA.119.14240
3. Satoh M, Ohkubo T, Miura K, et al. Long-term risk of cardiovascular mortality according to age group and blood pressure categories of the latest guideline. Hypertens Res. 2025;48, 1428–33. DOI: https://doi.org/10.1038/s41440-025-02151-w
4. Wu S, Wang Y, Wang J, et al. Modifiable factors and 10-year and lifetime cardiovascular disease risk in adults with new-onset hypertension: Insights from the Kailuan cohort. BMC Med. 202523(1):80. DOI: https://doi.org/10.1186/s12916-025-03923-4
5. Satoh M, Ohkubo T, Asayama K, et al. Evidence for cardiovascular prevention from observational cohorts in Japan (EPOCH–JAPAN) Research Group. A combination of blood pressure and total cholesterol increases the lifetime risk of coronary heart disease mortality: EPOCH-JAPAN. J Atheroscler Thromb. 2021;28(1):6–24. DOI: https://doi.org/10.5551/jat.52613
6. Imai Y, Hirata T, Saitoh S, et al. Evidence for cardiovascular prevention from observational Cohorts in Japan (EPOCH-JAPAN) Research Group. Impact of hypertension stratified by diabetes on the lifetime risk of cardiovascular disease mortality in Japan: A pooled analysis of data from the Evidence for Cardiovascular Prevention from Observational Cohorts in Japan study. Hypertens Res. 2020;43(12):1437–44. DOI: https://doi.org/10.1038/s41440-020-0502-5
7. Bragg F, Halsey J, Guo Y, et al. Blood pressure and cardiovascular diseases in Chinese adults with type 2 diabetes: A prospective cohort study. Lancet Reg Health West Pac. 2021;7:100085. DOI: https://doi.org/10.1016/j.lanwpc.2020.100085
8. Lewington S, Clarke R, Qizilbash N, et al., Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. The Lancet. 2002;360(9349):1903–13. DOI: https://doi.org/10.1016/s0140-6736(02)11911-8
9. Blood Pressure Lowering Treatment Trialists’ Collaboration. Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis. Lancet. 2021;397(10285):1625-36. DOI: https://doi.org/10.1016/S0140-6736(21)00590-0. Erratum in: Lancet. 2021;397(10288):1884. DOI: https://doi.org/10.1016/S0140-6736(21)01069-2
10. Stamler J, Stamler R, Neaton JD. Blood pressure, systolic and diastolic, and cardiovascular risks: US population data. Arch Intern Med. 1993;153(5):598–615. DOI: https://doi.org/10.1001/archinte.1993.00410050036006
11. Wierzejska E, Giernaś B, Lipiak A, et al. A global perspective on the costs of hypertension: A systematic review. Arch Med Sci. 2020;16(5):1078–91. DOI: https://doi.org/10.5114/aoms.2020.92689
12. World Health Organization. Hypertension. Key facts [internet]; 2023 [quoted 2024 Jul. 27]. Available on https://www.who.int/news-room/fact-sheets/detail/hypertension
13. Zhou B, Carrillo-Larco RM, Danaei G, et al. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: A pooled analysis of 1201 population-representative studies with 104 million participants. The Lancet. 2021;398(10304):957–80. DOI: https://doi.org/10.1016/S0140-6736(21)01330-1
14. Park JE, Park JH, Chang SJ, et al. The determinants of and barriers to awareness and treatment of hypertension in the Korean population. Asia Pac J Public Health. 2019;31(2):121–35. DOI: https://doi.org/10.1177/1010539518825006
15. Nejjari C, Arharbi M, Chentir MT, et al. Epidemiological Trial of Hypertension in North Africa (ETHNA): An international multicentre study in Algeria, Morocco and Tunisia. J Hypertension. 2013;31(1):49–62. DOI: https://doi.org/10.1097/HJH.0b013e32835a6611
16. World Health Organization. Rapport de l’enquête nationale sur les facteurs de risque communs des maladies non transmissibles (2017–2018) : rapport [Internet]. Rabat: WHO; 2021 [quoted 2024 Sep. 23]. Available from: https://cdn.who.int/media/docs/default-source/ncds/ncd-surveillance/data-reporting/morocco/steps/steps-report-2017-2018-morocco-final.pdf. French. [National survey report on common risk factors for noncommunicable diseases (2017–2018): report].
17. World Health Organization. WHO STEPS Surveillance Manual: The WHO STEPwise approach to chronic disease risk factor surveillance [internet]; 2017 [quoted 2024 Sep. 23]. Available on: https://www.who.int/docs/default-source/ncds/ncd-surveillance/steps/steps-manual.pdf
18. El Achhab Y, Nazek L, Maalej M, et al. Prevalence, control and risk factors related to hypertension among Moroccan adults: A multicentre study. East Mediterr Health J. 2019;25(7):447–56. DOI: https://doi.org/10.26719/emhj.18.057
19. Belayachi S, Boukhari FZ, Essayagh F, et al. Uncontrolled blood pressure and its risk factors among hypertensive patients, Marrakech, Morocco. Sci Rep. 2024;14(1):2953. DOI: https://doi.org/10.1038/s41598-024-53115-y
20. Essayagh T, Essayagh M, El Rhaffouli A, et al. Prevalence of uncontrolled blood pressure in Meknes, Morocco, and its associated risk factors in 2017. PLoS ONE. 2019;14(8):e0220710. DOI: https://doi.org/10.1371/journal.pone.0220710
21. Institute of Medicine (US) Committee on Public Health Priorities to Reduce and Control Hypertension. A population-based policy and systems change approach to prevent and control hypertension [Internet]. Washington (DC): National Academies Press (US); 2010 [quoted 2024 Sep 27]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK220084/. Summary, p. 7–8.
22. Campbell NRC, Paccot Burnens M, Whelton PK, et al. 2021 World Health Organization guideline on pharmacological treatment of hypertension: Policy implications for the region of the Americas. Lancet Reg Health Am. 2022;9:100219. DOI: https://doi.org/10.1016/j.lana.2022.100219
23. Mancia G, Kreutz R, Brunström M, et al. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). Journal Hypertens. 2023;41(12):1874–2071. DOI: https://doi.org/10.1097/HJH.0000000000003480
24. McEvoy JW, McCarthy CP, Bruno RM, et al. 2024 ESC guidelines for the management of elevated blood pressure and hypertension. Developed by the task force on the management of elevated blood pressure and hypertension of the European Society of Cardiology (ESC) and endorsed by the European Society of Endocrinology (ESE) and the European Stroke Organisation (ESO). Eur Heart J. 2024;45(38):3912–4018. https://doi.org/10.1093/eurheartj/ehae178
25. World Health Organization. WHO technical specifications for automated non-invasive blood pressure measuring devices with cuff [internet]; 2020 [quoted 2024 Jul. 27]. Available on: https://www.who.int/publications/i/item/9789240002654
26. Sedgwick P. Stratified cluster sampling. BMJ. 2013;347:f7016. DOI: https://doi.org/10.1136/bmj.f7016
27. Pu X, Gao G, et al. Parameter estimation in stratified cluster sampling under randomized response models for sensitive question survey. PLoS ONE. 2016;11(2):e0148267. DOI: https://doi.org/10.1371/journal.pone.0148267
28. Dos Santos Silva I. Cross-sectional surveys. In: Cancer epidemiology: Principles and methods [Internet]. Lyon: IARC Press; 1999, p. 213–229. [quoted 2024 Nov. 17]. Available on: https://publications.iarc.fr/_publications/media/download/4106/a72983d2524d630f6ad0539f747e4780447f1ae3.pdf.
29. Bierrenbach A. Steps in applying probability proportional to size (PPS) and calculating basic probability weights. In: Training workshops on TB prevalence surveys. Geneva: World Health Organization [internet]; 2008 [quoted 2024 oct. 12]; p. 1–5. Available on: https://cdn.who.int/media/docs/default-source/hq-tuberculosis/global-task-force-on-tb-impact-measurement/meetings/2008-03/p20_probability_proportional_to_size.pdf?sfvrsn
30. Wang X, Cheng Z. Cross-Sectional studies. Chest. 2020;158(1):S65–S71. DOI: https://doi.org/10.1016/j.chest.2020.03.012
31. Eaton WW, Kessler LG, editors. Epidemiologic field methods in psychiatry: The NIMH epidemiologic catchment area program. Elsevier Inc. [internet]; 2012 [cited 2025 May. 23]. Available from: https://shop.elsevier.com/books/epidemiologic-field-methods-in-psychiatry/eaton/978-0-08-091798-6
32. Haut-Comiisariat au Plan. Direction Régionale de Tanger-Tétouan-Al Hoceima. Monographie Provinciale de Tetouan [monograph on internet]. Tangier [internet] 2019 [quoted 2024 Sep. 27]. Available on https://www.hcp.ma/region-tanger/attachment/1835579/
33. Google Inc., cartographers. Morocco [map]. Mountain View (CA): Google Maps; [quoted 2024 Nov. 17]. Available on: https://www.google.com/maps/place/Morocco/@31.8008347,-7.1506879,3z/
34. Agence pour la Promotion et le Développement du Nord (APDN), cartographe. Présentation de la province de Tétouan [carte]. [Tanger-Tétouan-Al Hoceïma : APDN]; 2015 [quoted 2024 Nov. 17]. Available on: https://web.archive.org/web/20240626192914/http://www.apdn.ma/index.php?option=com_content&view=article&id=123&Itemid=151&lang=fr
35. Haut-Commissariat au Plan. Déterminants des transferts et des investissements des migrants marocains à l’étranger. Morocco [internet]. 2022 [quoted 2024 oct. 27]. Available on https://www.hcp.ma/Determinants-des-transferts-et-des-investissements-des-migrants-marocains-a-l-etranger_a3640.html
36. Giddens J. Demystifying concept-based and competency-based approaches. J Nurs Educ. 2020;59(3):123–24. DOI: https://doi.org/10.3928/01484834-20200220-01
37. Lewis LS, Rebeschi LM, Hunt E. Nursing education practice update 2022: Competency-based education in nursing. SAGE Open Nurs. 2022;8. DOI: https://doi.org/10.1177/23779608221140774
38. Roberts ML, Sinacori B, et al. Elevating competency-based education in baccalaureate nursing: A simulation integration project. J Prof Nurs. 2024;54:45–49. DOI: https://doi.org/10.1016/j.profnurs.2024.06.014
39. World Health Organization. EQUIP: Ensuring Quality in Psychological Support [Internet]. Geneva: WHO; [cited 2025 May. 22]. Available from: https://www.who.int/teams/mental-health-and-substance-use/treatment-care/equip-ensuring-quality-in-psychological-support
40. World Health Organization (WHO). Global competency framework for universal health coverage. Geneva: World Health Organization [internet]; 2022 [cited 2025 May. 22]. Available from: https://www.who.int/publications/i/item/9789240034686
41. Tangcharoensathien V, Calleja N, Nguyen T, et al. Framework for managing the COVID-19 infodemic: Methods and results of an online, crowdsourced WHO technical consultation. J Med Internet Res. 2020;22(6):e19659. DOI: https://doi.org/10.2196/19659
42. Al-Hazzaa HM. Health-enhancing physical activity among Saudi adults using the International Physical Activity Questionnaire (IPAQ). Public Health Nutr. 2007;10(1):59–64. DOI: https://doi.org/10.1017/S1368980007184299
43. BaHammam AS, Al-Aqeel AM, Alhedyani AA, et al. The validity and reliability of an Arabic version of the STOP-Bang questionnaire for identifying obstructive sleep apnea. TORMJ. 2015;9(1):22–9. DOI: https://doi.org/10.2174/1874306401509010022
44. Toft U, Kristoffersen LH, Lau C, et al. The Dietary Quality Score: Validation and association with cardiovascular risk factors: The Inter99 study. Eur J Clin Nutr. 2007;61(2):270–8. DOI: https://doi.org/10.1038/sj.ejcn.1602503
45. Noh SA, Kim HS, Kang SH, et al. History and evolution of blood pressure measurement. Clin Hypertens. 2024;30(1):9. DOI: https://doi.org/10.1186/s40885-024-00268-7
46. Takahashi H, Yoshika M, Yokoi T. Validation of three automatic devices for the self-measurement of blood pressure according to the European Society of Hypertension International Protocol revision 2010: The Omron HEM-7130, HEM-7320F, and HEM-7500F. Blood Press Monit. 2015;20(2):92–97. DOI: https://doi.org/10.1097/MBP.0000000000000096
47. Stergiou GS, Palatini P, Parati G, et al. 2021 European Society of Hypertension practice guidelines for office and out-of-office blood pressure measurement. J Hypertens. 2021;39(7):1293–302. DOI: https://doi.org/10.1097/HJH.0000000000002
48. Myers MG. Automated office blood pressure measurement. Korean Circ J. 2018;48(4):241–50. DOI: https://doi.org/10.4070/kcj.2018.0066
49. Bo Y, Kwok KO, Chu KK, et al. Comparison between automated office blood pressure measurements and manual office blood pressure measurements-Implications in individual patients: A systematic review and Meta-analysis. Curr Hypertens Rep. 2021;15;23(1):4. DOI: https://doi.org/10.1007/s11906-020-01118-1
50. Pasdar Y, Moradi S, Moludi J, et al. Waist-to-height ratio is a better discriminator of cardiovascular disease than other anthropometric indicators in Kurdish adults. Sci Rep. 2020;10(1):16228. DOI: https://doi.org/10.1038/s41598-020-73224-8
51. Holmes CJ, Racette SB. The utility of body composition assessment in nutrition and clinical practice: An overview of current methodology. Nutrients. 2021;13(8):2493. DOI: https://doi.org/10.3390/nu13082493
52. Vasold KL, Parks AC, Phelan DML, et al. Reliability and validity of commercially available low-cost bioelectrical impedance analysis. Int J Sport Nutr Exerc Metab. 2019;29(4):406–10. DOI: https://doi.org/10.1123/ijsnem.2018-0283
53. Singh A, Dangat DP, et al. Body composition analysis using Karada Scan in Indian collegiate population: An Observational Study. Medical Journal of Dr. D.Y. Patil Vidyapeeth. 2023;16(4):551–3. DOI: 10.4103/mjdrdypu.mjdrdypu_248_21
54. Ugras S. Evaluating of altered hydration status on effectiveness of body composition analysis using bioelectric impedance analysis. Libyan J Med. 2020;15(1):1741904. DOI: https://doi.org/10.1080/19932820.2020.1741904
55. Johnson Stoklossa CA, Forhan M, Padwal RS, et al. Practical considerations for body composition assessment of adults with class II/III obesity using bioelectrical impedance analysis or dual-energy X-ray absorptiometry. Curr Obes Rep. 2016;5(4):389–96. DOI: https://doi.org/10.1007/s13679-016-0228-5
56. IBM Corp. IBM SPSS Statistics for Windows, Version 27.0. Armonk, NY: IBM Corp. 2020.
57. Waller JL, Addy CL, Jackson KL, Garrison CZ. Confidence intervals for weighted proportions. Stat Med. 1994;13(10):1071–82. DOI: https://doi.org/10.1002/sim.4780131009
58. World Medical Association. Declaration of Helsinki. Ethical principles for medical research involving human subjects. 75th General Assembly. Helsinki, Finland [internet]; 2024 [quoted 2024 Nov. 1]. Available on: https://www. wma.net/policies-post/wma-declaration-of-helsinki-ethicalprinciples-for-medical-research-involving-human-subjects/
59. Low GK, Subedi S, Omosumwen OF, et al. Development and validation of observational and qualitative study protocol reporting checklists for novice researchers (ObsQual checklist). Evaluation and Program Planning. 2024;106:102468. DOI: https://doi.org/10.1016/j.evalprogplan.2024.102468
60. Fodor JG, Leenen FHH, et al. 2006 Ontario Survey on the Prevalence and Control of Hypertension (ON-BP): Rationale and design of a community-based cross-sectional survey. Can. J. Cardiol. 2008;24(6):503–5. DOI: https://doi.org/10.1016/s0828-282x(08)70626-3
61. Wang Z, Zhang L, Chen Z, et al. Survey on prevalence of hypertension in China: Background, aim, method and design. Int. J. Cardiol. 2014;174(3):721–3. DOI: https://doi.org/10.1016/j.ijcard.2014.03.117
Descargas
Publicado
Cómo citar
Licencia
Derechos de autor 2025 Universidad de Antioquia
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.
El autor o los autores conserva(n) los derechos morales y cede(n) los derechos patrimoniales que corresponderán a la Universidad de Antioquia, para publicarlo, distribuir copias electrónicas, incluirlas en servicios de indización, directorios o bases de datos nacionales e internacionales en Acceso Abierto, bajo la licencia Creative Commons Atribución-No Comercial-Compartir Igual 4.0 Internacional Comercial (CC BY-NC-SA) la cual permite a otros distribuir, remezclar, retocar y crear a partir de la obra de modo no comercial, siempre y cuando se dé crédito respectivo y licencien las nuevas creaciones bajo las mismas condiciones.
--
--
--
